Project Grant R01EY035623
Award Date
9/30/24
Completion Date
4/30/29
Dollars Obligated
$362K
Federal Agency
National Eye Institute
Federal Grant Program
93.867
Assistance Type
Project Grant
Place of Performance
Birmingham, AL 35294, USA
Similar Awards
This Project Grant award from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), provides $234,000.00 to Oregon Health & Science University (OHSU) to research restoring intraocular pressure (IOP) homeostatic function in glaucomatous eyes. The project aims to use senolytic treatments and senoreversion therapies, either alone or in combination with stem cell transplantation, to address IOP dysregulation and vision loss associated with glaucoma. The award...
This $185,000 Project Grant award from the National Eye Institute (NEI) under CFDA 93.867 (Vision Research) supports research to discover novel disease-modifying therapies for the prevention and treatment of glaucoma. The primary awardee, the University of North Texas Health Science Center at Fort Worth, will employ computational pharmacology approaches to identify small molecule inhibitors that can interfere with the GREM1-BMP protein-protein interaction, a key pathogenic mechanism contributing...
This federal Project Grant award, totaling $496,633, was awarded by the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867). The grant supports a research project at Duke University to investigate the role of glypicans, specifically glypican-4 (GPC4), in trabecular meshwork function, intraocular pressure regulation, and the development of glaucoma. The project aims to uncover the molecular mechanisms by which augmented GPC4 expression and secretion may dysregulate Wnt...
The National Eye Institute (NEI), under the Department of Health and Human Services, has awarded a $568,122 Project Grant (CFDA 93.867 - Vision Research) to Baylor College of Medicine. The grant, effective from July 1, 2025, through March 31, 2030, aims to confirm the contribution of the neurovascular unit (NVU) to the pathogenesis of glaucoma and identify endothelial cell-specific ligands with potential for neuroprotective therapy. The key objectives of this project are to: 1) globally map...
This Project Grant award from the National Eye Institute (NEI), under the federal Vision Research program (CFDA 93.867), supports research to investigate the combined effects of aging and elevated intraocular pressure (IOP) on the development of glaucoma and retinal ganglion cell (RGC) transcriptomics, as well as determine how transient epigenetic reprogramming using a gene therapy can reverse these age- and glaucoma-specific transcriptomic changes and restore visual function. The total award...
This $460,625 Project Grant was awarded by the National Eye Institute (NEI) under the Vision Research federal grant program (CFDA 93.867) to Yale University. The grant will fund research to investigate the cellular and synaptic mechanisms underlying changes in retinal ganglion cell (RGC) activity following optic nerve injuries in mouse models of glaucoma. Specifically, the project aims to (1) determine the underlying mechanisms for altered RGC activity after increased intraocular pressure or...
This Project Grant award from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) provides $1,066,178 to Tavo Biotherapeutics, Inc. (operating as Oculo Therapy LLC) to support late-stage preclinical development and GMP production of a novel extended-release intraocular pressure (IOP)-lowering formulation for the treatment of glaucoma. The funding will enable critical IND-enabling studies for this first-in-class drug candidate using the FDA-approved drug pregabalin as...
This Project Grant award from the National Eye Institute (NEI), under the federal Vision Research program (CFDA 93.867), is supporting research to develop and validate a novel method for measuring ocular pulse amplitude (OPA) using applanation-based tonometers. The award, totaling $245,243, will be used to pursue two specific aims: 1) validate the OPA measurement approach on non-human primates with implanted intraocular pressure telemetry systems, and 2) assess the repeatability and...
This Project Grant award from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), will support research to investigate the molecular mechanisms underlying trabecular meshwork cell loss and cytotoxicity caused by mutant myocilin misfolding in glaucoma. The $447,479 award to Georgia TECH Research Corp will enable a 5-year research project to: 1) Screen a yeast gene deletion library to identify genes that can restore cell viability when mutant myocilin is expressed,...
This federal Project Grant award of $715,098 from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) aims to enhance glaucoma risk prediction through advanced genomics and machine learning. The key products and services to be delivered include: Improving polygenic risk score (PRS) performance for glaucoma by leveraging natural language processing techniques and electronic health record data from over 68,000 patients to extract refined glaucoma phenotypes. The...